HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.

Abstract
Topical application of imiquimod (IMQ) on the skin of mice induces inflammation with common features found in psoriatic skin. Recently, it was postulated that IL-17 has an important role both in psoriasis and in the IMQ model. To further investigate the impact of IL-17RA signaling in psoriasis, we generated IL-17 receptor A (IL-17RA)-deficient mice (IL-17RA(del)) and challenged these mice with IMQ. Interestingly, the disease was only partially reduced and delayed but not abolished when compared with controls. In the absence of IL-17RA, we found persisting signs of inflammation such as neutrophil and macrophage infiltration within the skin. Surprisingly, already in the naive state, the skin of IL-17RA(del) mice contained significantly elevated numbers of Th17- and IL-17-producing γδ T cells, assuming that IL-17RA signaling regulates the population size of Th17 and γδ T cells. Upon IMQ treatment of IL-17RA(del) mice, these cells secreted elevated amounts of tumor necrosis factor-α, IL-6, and IL-22, accompanied by increased levels of the chemokine CXCL2, suggesting an alternative pathway of neutrophil and macrophage skin infiltration. Hence, our findings have major implications in the potential long-term treatment of psoriasis by IL-17-targeting drugs.
AuthorsKhalifa El Malki, Susanne H Karbach, Jula Huppert, Morad Zayoud, Sonja Reissig, Rebecca Schüler, Alexej Nikolaev, Khalad Karram, Thomas Münzel, Christoph R W Kuhlmann, Heiko J Luhmann, Esther von Stebut, Simone Wörtge, Florian C Kurschus, Ari Waisman
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 133 Issue 2 Pg. 441-51 (Feb 2013) ISSN: 1523-1747 [Electronic] United States
PMID22951726 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Aminoquinolines
  • Il17a protein, mouse
  • Il17ra protein, mouse
  • Interleukin-17
  • Interleukin-6
  • Interleukins
  • Receptors, Interleukin-17
  • interleukin-6, mouse
  • Imiquimod
  • interleukin-22
Topics
  • Adjuvants, Immunologic (pharmacology)
  • Aminoquinolines (pharmacology)
  • Animals
  • Disease Models, Animal
  • Female
  • Imiquimod
  • Interleukin-17 (immunology, metabolism)
  • Interleukin-6 (immunology, metabolism)
  • Interleukins (immunology, metabolism)
  • Macrophages (drug effects, immunology)
  • Mice
  • Mice, Knockout
  • Neutrophil Infiltration (drug effects, immunology)
  • Psoriasis (chemically induced, genetics, immunology)
  • Receptors, Interleukin-17 (genetics, immunology, metabolism)
  • Signal Transduction (drug effects, immunology)
  • Skin (immunology, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: